By Sougato Das, President and COO, LSN
Securing investment is rarely about delivering the perfect pitch. Successful fundraising is built on understanding how investors evaluate opportunities, developing meaningful relationships, and communicating a compelling value proposition that stands up to diligence.
On Thursday, July 9, at 12:00 PM ET, Life Science Nation will bring together an outstanding panel of active life science investors for an in-depth discussion on what it takes to raise capital in today’s investment environment. The webinar will feature George Voren, VP of Founder Strategy and Operations at Curie.Bio; Yaniv Sneor, Founder of Mid Atlantic Bio Angels; Anna Crespo Puig, Investment Analyst at AdBio Partners; and Ankita Das, Senior Venture Development Associate, Therapeutics, at NLC Health Ventures. Together, they represent a diverse range of investment perspectives spanning venture creation, angel investing, venture capital, and strategic venture development.
 George Voren Curie.Bio |
 Yaniv Sneor Mid Atlantic Bio Angels |
 Anna Crespo Puig AdBio Partners |
 Ankita Das NLC Health Ventures |
Moderated by Life Science Nation, the conversation is designed to deliver actionable insights for entrepreneurs preparing to raise capital, whether they are beginning their fundraising journey or actively engaging investors.
As market conditions continue to evolve, founders are navigating an increasingly competitive fundraising landscape. This webinar will provide practical guidance on how investors are approaching new opportunities, what they expect to see in executive summaries and pitch decks, how entrepreneurs can secure productive investor meetings both inside and outside partnering conferences, and the common mistakes that can derail an otherwise promising opportunity. The panel will also discuss what founders should expect once discussions move beyond a confidentiality agreement and into deeper diligence.
Reserve your spot today and join Life Science Nation on July 9 at 12:00 PM ET for this timely discussion.
| Sign Up for the Investor Webinar |
Next Phase Newsletter 
Leave a comment